Bumper Offer - Urjas oil Just @ Rs. 1
Omniderm (Embiotic) is a prescription medicine that is available as a Cream. Primarily, it is used for the treatment of Seborrheic Dermatitis, Dermatitis. The alternative uses of Omniderm (Embiotic) have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Omniderm (Embiotic). Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Omniderm (Embiotic) can also lead to other problems, which have been listed below. Normally, these side effects of Omniderm (Embiotic) are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Omniderm (Embiotic) has a Unknown effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Omniderm (Embiotic)'s effects on the liver, heart and kidney, if any, have been listed below.
Some other conditions that can be affected by Omniderm (Embiotic) are listed in the contraindications section below.
Drug interactions for Omniderm (Embiotic) have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Omniderm (Embiotic) is safe while driving, and is is addictive in nature.
Omniderm (Embiotic) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Omniderm (Embiotic) is used -
Moderate
Mild
Is the use of Omniderm (Embiotic) safe for pregnant women?
The effects of Omniderm (Embiotic) on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Omniderm (Embiotic) safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Omniderm (Embiotic) for breastfeeding women are not known.
What is the effect of Omniderm (Embiotic) on the Kidneys?
Omniderm (Embiotic) is completely safe for kidneys.
What is the effect of Omniderm (Embiotic) on the Liver?
Using Omniderm (Embiotic) does not have any harmful effects on the liver.
What is the effect of Omniderm (Embiotic) on the Heart?
Very few cases of side effects of Omniderm (Embiotic) on the heart have been reported.
Omniderm (Embiotic) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Omniderm (Embiotic) unless your doctor advises you to do so -
Is this Omniderm (Embiotic) habit forming or addictive?
No, you will not get addicted to Omniderm (Embiotic).
Is it safe to drive or operate heavy machinery when consuming?
Omniderm (Embiotic) will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Omniderm (Embiotic) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Omniderm (Embiotic) cannot treat any kind of mental disorder.
Interaction between Food and Omniderm (Embiotic)
Due to the absence of research, it is difficult to say how Omniderm (Embiotic) and food will interact.
Interaction between Alcohol and Omniderm (Embiotic)
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Omniderm (Embiotic).
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Synalar® (fluocinolone acetonide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 370
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Synalar® (fluocinolone acetonide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 370
